I've been digging through the latest peptide research papers, and some findings have completely flipped my assumptions. Like how semaglutide users are showing up to 40% lower rates of alcohol use disorder in retrospective studies — nobody saw that neurological crossover coming when it was just a diabetes drug.
Or how TB-500's systemic distribution means you don't need localized injection sites for tissue repair effects. That goes against everything we thought about peptide delivery.
What's caught you off guard in your research this year? Maybe an unexpected result that made you rethink a compound's mechanism? Or finding synergy between peptides you never thought would work together? Even negative results that saved you from going down the wrong path?
I'm curious what discoveries — big or small — have shifted how you approach peptide research. The field moves so fast that last year's assumptions become this year's outdated thinking.
*For research purposes only. Not for human consumption.*